Does Amphotericin B Liposome Interact with Flucytosine?
Amphotericin B Liposome and Flucytosine have a moderate drug interaction according to U.S. FDA drug labeling data. Concurrent use may increase flucytosine toxicity by possibly increasing cellular uptake and/or impairing renal excretion. The mechanism involves increased cellular uptake and/or impaired renal excretion. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Amphotericin B Liposome Class
- Lipid-based Polyene Antifungal
- Flucytosine Class
- Nucleoside Analog Antifungal
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Amphotericin B Liposome and Flucytosine occurs because increased cellular uptake and/or impaired renal excretion. Clinically, this means concurrent use may increase flucytosine toxicity by possibly increasing cellular uptake and/or impairing renal excretion. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Amphotericin B Liposome and your doctor is considering prescribing Flucytosine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider